A Study of Vismodegib (GDC-0449) in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma

Pembrolizumab With or Without Vismodegib in Treating Metastatic or Unresectable Basal Cell Skin Cancer

NCT02690948 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

To Assess The Efficacy And Safety Of Vismodegib And Radiotherapy In Advanced Basal Cell Carcinoma

NCT02956889 ·Status: TERMINATED ·Phase: PHASE2

Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study

NCT05463757 ·Status: RECRUITING

Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas

NCT02639117 ·Status: COMPLETED ·Phase: PHASE1

Mohs Versus Traditional Surgery - Basal-Cell Carcinomas (BCC)

NCT00699829 ·Status: UNKNOWN

An Observational Study of Treatment Patterns and Effectiveness and Safety Outcomes in Advanced Basal Cell Carcinoma and Basal Cell Carcinoma Nevus Syndrome Patients(RegiSONIC)

NCT01604252 ·Status: TERMINATED

Study Evaluating the Efficacy and Safety of 0.05% Ingenol Mebutate (Picato® 500) in the Treatment of Basal Cell Carcinoma

NCT03546166 ·Status: COMPLETED ·Phase: PHASE2

Study of Intratumoral CV8102 in cMEL, cSCC, hnSCC, and ACC

NCT03291002 ·Status: UNKNOWN ·Phase: PHASE1

L19IL2/TNF in Patients With Basal Cell Carcinoma

NCT07227870 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Study of MDX-010 in Subjects With Unresectable Stage III or Stage IV Malignant Melanoma

NCT00729950 ·Status: COMPLETED ·Phase: PHASE1

L19IL2 or L19TNF or L19IL2/TNF in Patients With Basal Cell Carcinoma (BCC)

NCT07227350 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Phase I Study of Intralesional Bacillus Calmette-Guerin (BCG) Followed by Ipilimumab in Advanced Metastatic Melanoma

NCT01838200 ·Status: TERMINATED ·Phase: PHASE1

Evaluation of Efficacy and Safety of Cemiplimab as First Line Treatment for Advanced Basal Cell Carcinoma (BCC) Patients

NCT06981325 ·Status: RECRUITING ·Phase: PHASE2

Study to Compare the Efficacy and Safety of CC-5013 vs. Placebo in Subjects With Metastatic Malignant Melanoma.

NCT00057616 ·Status: COMPLETED ·Phase: PHASE3

Curettage Versus Excision in Nodular and Superficial Basal Cell Carcinomas

NCT00515970 ·Status: SUSPENDED ·Phase: NA

Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma

NCT00055562 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Expanded Access Study of Talimogene Laherparepvec for Treatment of Subjects With Unresected Stage IIIB-IVM1c Melanoma

NCT02297529 ·Status: NO_LONGER_AVAILABLE

mRNA Electroporated Autologous Dendritic Cells for Stage III/IV Melanoma

NCT01676779 ·Status: COMPLETED ·Phase: PHASE2

Surgery Versus Combined Treatment With Curettage and Imiquimod for Nodular Basal Cell Carcinoma

NCT02242929 ·Status: UNKNOWN ·Phase: PHASE3

O6-Benzylguanine and Topical Carmustine in Treating Patients With Early-Stage IA-IIA Cutaneous T-Cell Lymphoma

NCT00961220 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Recurrence Rate and Esthetic Outcome After Excision of Basal Cell Carcinomas Excluded From Trial NCT00515970

NCT00639652 ·Status: UNKNOWN

Safety and Efficacy Study of a New Chemotherapy Agent to Treat Metastatic Melanoma

NCT00185302 ·Status: COMPLETED ·Phase: PHASE2

A Study of Vemurafenib and GDC-0973 (Cobimetinib) in Participants With BRAFV600E Mutation-Positive Metastatic Melanoma

NCT01271803 ·Status: COMPLETED ·Phase: PHASE1

Phase 2 Study of Intralesional PV-10 for Metastatic Melanoma

NCT00521053 ·Status: COMPLETED ·Phase: PHASE2

Real-world Evaluation of Diagnostic and Treatment Strategies in Low-Risk Basal Cell Carcinoma

NCT06252857 ·Status: RECRUITING